Debut Plus

₹17.22

▲ +0.82 +5.00%

18 Jul 2026

BSE Listed

GSM 0

Norris Medicines Ltd. (524414)

Volume: 1,675Avg Vol 1W: 2,619Avg Vol 1M: 2,73552W Range:₹12₹19.63
BSE www.norrispharma.com
Key Ratios
Checked 6h ago
Market Cap₹17 Cr
Current Price₹17.22
Previous Close₹16.4
High / Low (52w)₹19.63 / ₹12
Volume1,675
Avg Vol (1W)2,619
Avg Vol (1M)2,735
Stock P/E—
Book Value₹-15.07
Dividend Yield0%
ROE185.24%
ROA-217.22%
Revenue (TTM)—
Revenue Growth—
Profit Margin-343.98%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹14.44
200 DMA₹14.82
Day change+5.00%
SurveillanceGSM 0 (as of 2026-07-18)
Price Chart
₹17.22▼ 2.05% · 1Y
₹19₹1210K
2025-07-18
2026-07-17

20-day avg volume: 3K shares

Pros
  • Healthy return on equity of 185.2%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1 Cr₹1 Cr₹1 Cr₹3 Cr₹1 Cr₹2 Cr₹3 Cr₹1 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹1 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹1 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹14 Cr₹16 Cr₹8 Cr₹12 Cr₹9 Cr₹8 Cr₹6 Cr₹6 Cr
EBITDA₹-2 Cr₹-1 Cr₹-3 Cr₹-2 Cr₹-1 Cr₹0 Cr₹-1 Cr₹-1 Cr
Net Profit₹-3 Cr₹-2 Cr₹-3 Cr₹-5 Cr₹-3 Cr₹-2 Cr₹-1 Cr₹-1 Cr
EPS-2.51-1.68-2.84-4.96-3.26-1.75-1.19-1.24
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹21 Cr₹20 Cr₹21 Cr₹20 Cr₹14 Cr₹14 Cr₹14 Cr₹14 Cr
Total Liabilities₹19 Cr₹20 Cr₹23 Cr₹27 Cr₹25 Cr₹26 Cr₹28 Cr₹29 Cr
Equity₹2 Cr₹0 Cr₹-2 Cr₹-7 Cr₹-11 Cr₹-12 Cr₹-14 Cr₹-15 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹-1 Cr₹1 Cr₹0 Cr₹1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹-1 Cr₹1 Cr₹-1 Cr₹0 Cr₹-1 Cr
Free Cash Flow₹1 Cr₹-1 Cr₹1 Cr₹0 Cr₹1 Cr
Shareholding
Promoter 34.01% Institutions 0.07% Public 65.92%
Efficiency & Working Capital
ROCE3.4%
Interest Coverage-1.7
Dividend Payout—
Debtor Days88 d
Inventory Days259 d
Payable Days161 d
Cash Conversion Cycle186 d
Working Capital Days347 d
Shareholding Details

As of 2026-03-31

Promoter34%
FII0%
DII0.1%
Institutions0.1%
Public65.9%
Promoter Pledge0%
No. of Shareholders25,777
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters34%34%34%34%34%34%34%34%34%34%34%34%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%
Public65.9%65.9%65.9%65.9%65.9%65.9%65.9%65.9%65.9%65.9%65.9%65.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders25,25625,24225,31725,51725,40025,49825,65925,81525,95025,89525,79125,777
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Vimal D ShahShareholding of Promoter and Promoter Group23.6%23,60,441
Navsarjan Investment & Trading Pvt LtdShareholding of Promoter and Promoter Group10%10,00,000
Lkp Securities LimitedPublic Shareholding1.5%1,50,000
Dhirendra Kantilal Shah HufShareholding of Promoter and Promoter Group0.3%34,350
Navnit Jethabhai PatelShareholding of Promoter and Promoter Group0%3,840
Milind L UpadhyayaShareholding of Promoter and Promoter Group0%1,500
Nimish Bhishma ThakoreShareholding of Promoter and Promoter Group0%1,440
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Vimal D Shah00%2026-03-31
Dhirendra Kantilal Shah Huf00%2026-03-31
Navnit Jethabhai Patel00%2026-03-31
Milind L Upadhyaya00%2026-03-31
Nimish Bhishma Thakore00%2026-03-31
Navsarjan Investment & Trading Pvt Ltd00%2026-03-31
Lkp Securities Limited00%2026-03-31
Vimal D Shah00%2025-12-31
Dhirendra Kantilal Shah Huf00%2025-12-31
Navnit Jethabhai Patel00%2025-12-31
Milind L Upadhyaya00%2025-12-31
Nimish Bhishma Thakore00%2025-12-31
Board of Directors
NameDesignationYear
Vimal D ShahChairman / Executive Director / Managing Director2025
Angamuthu VadivelIndependent Non Exe. Director2025
Praveen BafnaNon-Exec & Non-Independent Dir2025
Sathya VenkatachalamIndependent Non Exe. Director2025
Priyanka LohiaCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10101010
Company Information
Incorporated1990
ChairmanVimal D Shah
AuditorBahedia & Associates
Investor Email[email protected]; [email protected]
🌐 www.norrispharma.com ↗

📍 Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Vimta LabsBiofil ChemicalsIshita Drugs & IndustriesMarksans PharmaUniversal Starch-Chem AllAarey Drugs & PharmaceuticalsAsian Petroproducts & ExpCamex Ltd.Evexia Lifecare LimitedIndo Euro Indchem Ltd.Syncom FormulationsRiddhi Siddhi Gluco BiolsAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search